Canada markets open in 18 minutes
  • S&P/TSX

    -224.53 (-1.38%)
  • S&P 500

    -64.42 (-1.86%)
  • DOW

    -650.19 (-2.29%)

    +0.0017 (+0.22%)

    -0.02 (-0.05%)

    +349.60 (+2.02%)
  • CMC Crypto 200

    +3.60 (+1.37%)

    +1.50 (+0.08%)
  • RUSSELL 2000

    -35.29 (-2.15%)
  • 10-Yr Bond

    -0.0170 (-2.12%)
  • NASDAQ futures

    +35.50 (+0.31%)

    +4.90 (+17.79%)
  • FTSE

    -13.84 (-0.24%)
  • NIKKEI 225

    -8.54 (-0.04%)

    +0.0002 (+0.03%)

CVAT Announces Kickstarter Campaign for Product Using Their Technology

Chatsworth, CA, Oct. 28, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Cavitation Technologies, Inc.’s (CTi) (OTCQB: CVAT) (WTC.BE), strategic partner, Alchemy Beverages, Inc. (ABI) launches a successful Kickstarter campaign

Alchemy Beverages Inc. (ABI), the licensing partner of CTi’s patented technology for altering composition and accelerating the conversion of ingredients to enhance flavors and taste profiles of alcoholic beverages, while mitigating the presence of harsh acids, has successfully launched its Barmuze home device on Kickstarter.

CTi is a major shareholder in ABI and will receive royalty payments from all revenues associated with their licensed technology.

This home product has been in development for several years and the final design and prototype is now fully completed. ABI has begun taking pre-orders on Kickstarter and expects to begin shipping these first units to consumers in May 2020.

“This is one of the most exciting uses for our proprietary technology,” says Roman Gordon, CTi’s founder and Technology Manager. “This is the first consumer product encompassing our patented technology and we are excited to work with ABI to see this product fully functional and available to the consumer market.”

Barmuze is set to take advantage of the consumer’s desire to have a cleaner drink and a healthier lifestyle. Verified by several independent laboratory and university studies, utilizing CTi’s patented technology in Barmuze, a substantial portion of the impurities present in the original brands is substantially reduced. In addition, Barmuze reduces much of the unpleasant harshness by converting unpleasant acids into pleasant tasting esters.

“Bottom line is, the consumer can enjoy a better tasting drink with much less of the bad stuff -- and maybe even a better morning after,” said Mark Geist, CEO of ABI. He continued, “With the launch of our successful Kickstarter we have taken the first step to get this game changing technology and product into the hands of the consumer. The campaign started on October 7 and will close on November 14. We welcome everyone to go to Kickstarter and become an early adapter.”

About CTi
Founded in 2007, the company designs and manufactures innovative flow-through devices and systems, as well as develops processing technologies for use in edible oil refining, renewable fuel production, water treatment, and alcoholic beverage enhancement. The company's patented Nano Reactor® systems and various technologies have over 30 patents issued and filed both domestically and abroad.

Follow us on Twitter for real time updates:

Like us on Facebook to receive live feeds updates:

Check us out on LinkedIn:

About ABI

Alchemy Beverages Inc. (ABI) was established in 2018 to introduce the proprietary and patented Clarification Technology to the market. ABI is changing the way alcohol is produced and consumed. Dedicated to democratizing the experience of responsible drinking, with their first to market product, Barmuze, they are empowering consumers to drink the best possible version of their favorite spirit.

Like & Follow Barmuze on Facebook:

Follow Barmuze on Instagram:

Forward Looking Statement
This release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. In some cases forward-looking statements can be identified by terminology such as "may," "should," "potential," "continue," "expects," "anticipates," "intends," "plans," "believes," "estimates," and similar expressions, and include statements regarding the anticipated installation and the timing of the installation, our intent to continue to focus on research and development, marketing and sales of our unique technology, our belief that our company is positioned for accelerated growth and the expected efforts to be made to enhance our shareholder's value. These forward-looking statements are based largely on the Company's expectations and are subject to a number of risks and uncertainties, certain of which are beyond the Company's control. Actual results could differ materially from these forward looking statements as a result of a variety of factors including, among others, the state of the economy, the competitive environment and our ability to perform the installation as anticipated and other factors described in our most recent Form 10-K and our other filings with the SEC, including subsequent periodic reports on Forms 10-Q and 8-K. In light of these risks and uncertainties there can be no assurances that the forward-looking statements contained in this press release will in fact transpire or prove to be accurate. The information in this release is provided only as of the date of this release, and we undertake no obligation to update any forward-looking statements contained in this release on account of new information, future events, or otherwise, except as required by law.

Cavitation Technologies, Inc.


Investor Relations

Phone (818) 718-0905